About Us

About Us (8)

Wednesday, 24 September 2014 00:00

Our Core Values

Written by

In conducting its functions, the Institute will uphold the following guiding principles:

Ø  Loyalty

Ø  Honesty

Ø  Team work and commitment

Ø  Professionalism

Ø  Innovativeness

Ø  Integrity, Accountability and transparency

Ø  Partnerships

Corporate Social Responsibility

Wednesday, 24 September 2014 00:00

Our Core Function

Written by

The Institute is expected to deliver on the following:

Ø  Co-ordinate and take charge of all veterinary vaccines production in the country.

Ø  Research, either alone or in collaboration with other research institutions, into new innovations of veterinary vaccines production.

Ø  Develop and produce chemicals, media and laboratory products for use in the production of vaccines and other veterinary products.

Ø  Market and distribute veterinary vaccines locally and abroad.

Provide information in the field in other activities as the Board with the approval of the President may determine.

Wednesday, 24 September 2014 00:00

Mission, Vision and Mandate

Written by

Our Mission

To produce safe, efficacious and affordable veterinary vaccines through undertaking research, providing information, marketing and distribution for improvement of the livestock industry.

Our Vision

A globally recognized institute in the production and supply of high quality and affordable veterinary vaccines and services.

Our Mandate

The Kenya Veterinary Vaccines Production Institute (KEVEVAPI) derives it mandate under the State Corporations Act, Cap 446 of the laws of Kenya through legal notice No. 223 of 4th June, 1990.

Wednesday, 24 September 2014 00:00

Role of KEVEVAPI in Economy

Written by

Most of livestock diseases are endemic and pose severe constrains to the livestock industry. They cause economic losses through deaths and decreased production. Some countries like the United States of America and Great Britain have used slaughter and compensation policy in control of Foot and Mouth and New Castle diseases. However, it is a very expensive policy for a developing country like Kenya to undertake. The only affordable alternative is vaccination; hence the more the need for a functional local veterinary vaccines production facility, thus KEVEVAPI, to provide the appropriate vaccines for the country. The Institute has been in existence as a Centre under Kenya Agricultural Research Institute (KARI) and has been producing vaccines to meet the local demand. This has enhanced the livestock industry to contribute to the GDP.

Wednesday, 24 September 2014 00:00

Achievements

Written by

Ø  Facilities to  produce wide range of vaccines

Ø  Experienced human resource base

Ø  Possession of vaccine master seeds

Ø  Appropriate storage facilities

Ø  Vaccines produced from local isolates

Ø  30 years experience in vaccine production

Ø  Main  producer of inactivated CCPP vaccine world wide

Ø  Efficiency in  production

Ø  Strong distributor network in the region

Ø  Strong linkage with local, regional and international research organizations

Wednesday, 24 September 2014 00:00

Livestock Sector Contribution

Written by

The livestock sector contributes about 12% of Kenya’s Gross Domestic Product (GDP), 40% to the agricultural GDP and employs 50% of agricultural labor force.  About 60% of Kenya’s livestock herd is found in the arid and semi-arid lands (ASALs), which constitute about 80% of the country.  It is estimated that 10 million Kenyans living in the ASALs derive their livelihood largely from livestock. Livestock play important roles in Kenya’s socio-economic development and contribute towards household food and nutritional security.
The stakeholders in the sector have recognized the role that a vibrant livestock industry can play to reverse the poverty levels and contribute to the nation’s economic growth. The recognition is emphasized in various government policy documents such as the ninth National Development Plan – 2002 -2008, Poverty Reduction Strategy Paper (PRSP), Economic Recovery Strategy for Wealth and Employment Creation (ERSWEC) -2003 to 2007, Strategy for Revitalizing Agriculture (SRA) 2004 – 2014, Kenya Vision 2030, Millennium Development Goals (MDGs) and the National Livestock Policy (NLP). 
Despite the economic significance, the major challenge is livestock disease outbreaks. For instance, Kenya experienced two major disease outbreaks over the past two years resulting in the imposition of disease-related export restrictions. These had a negative impact on recovery of trade in livestock and livestock products. 
Supportive role in Livestock Production: Kenya possesses one of the best livestock industries in East and Central Africa. However, diseases which exist either in enzootic or epidemic states are the major constrains in livestock production. Nevertheless, these diseases can either be controlled by vaccination or treatment. Vaccination is the most sustainable method of control and covers large proportions of animal herds. Most common livestock vaccines developed in Kenya and are manufactured by the Institute include: Rinderpest vaccine, Contagious Bovine Pleuropneumonia and Contagious Caprine Pleuropneumonia. The Institute owns seed stock. 
Supportive role in Food Security: KEVEVAPI contributes to the food security and sustainable livelihoods of Kenyans by provision of vaccines used in control of major diseases in cattle, small ruminants and poultry. 
Role in Management of Zoonotic Diseases: Rabies and Rift Valley Fever are two important diseases of animals that are transmissible to man. The Institute manufactures both RVF and rabies vaccines. The wide usage of vaccine against rabies disease has resulted in the dramatic reduction of human cases in Kenya. The Institute’s quick response in production of recent RVF vaccine greatly influenced the control of RVF epidemics in both Kenya and Tanzania.
Control of Notifiable and Emerging Disease Outbreaks: An outbreak of any notifiable disease in the country is a great challenge to livestock production, export markets as well as in the cost of sanitary measures taken to contain the disease. To forestall such losses, quantities of veterinary vaccines for strategic use must be readily available for control of notifiable disease outbreaks. Indeed, the government’s perception expects the Institute to produce adequate reserves of vaccines for strategic use by the Director of Veterinary Services for public good. The strategic vaccines reserve includes those against: Foot and Mouth, Rinderpest, Contagious Bovine Pleuropneumonia, Rabies, Rift Valley Fever, Blue Tongue, LSD, PPR and New Castle.

Wednesday, 24 September 2014 00:00

Legal and Institutional Framework

Written by

The Kenya Veterinary Vaccines Production Institute (KEVEVAPI) was established as a parastatal institution under, Cap 446 of the laws of Kenya on 5th May 1990 through legal Notice No. 223 of 4th June, 1990. This followed the dissolution of a joint venture between the Government of the Republic of Kenya and the Wellcome Trust Foundation of the United Kingdom. The Institute was created by merging three different institutions that were producing vaccines in Kenya and included the Vaccine Production Laboratory (VPL) at Embakasi, the vaccine production section at the KARI- National Veterinary Research Centre (NVRC) at Muguga and the vaccine section of Veterinary Research Laboratory at Department of Veterinary Services Headquarter at Kabete.

Wednesday, 24 September 2014 00:00

Background

Written by

The history of state owned corporations can be traced to the days of colonial rule in Kenya. State corporations were established mainly in the transport, communications and agricultural sectors of the economy so as to enhance the exploitation of the territorial resources. With the attainment of independence, the Government, through sessional paper No. 10 of 1965 on “African Socialism and its Application to Planning in Kenya” announced a series of policy initiatives that emphasized the complimentary roles of the public and private sectors in national development. 
Development strategies aimed at increasing indigenous participation in the economy, promoting development and regional balance and attaining greater control of the economy were mooted. In order to speed up the achievements of these objectives, the government established more state corporations in other sectors of the economy.

Find Us Here

Kenya Veterinary Vaccines Production Institute

P.O. BOX 53260 00200 
Head Office, Embakasi off Enterprise Road, Road A,
NAIROBI, KENYA

Join Our Mailing List